Safety and Performance of the Glyconics-SX System (ANODE02)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT05476016
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Glyconics Ltd
- Registry
-
NCT05476016
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT05476016. Allocation not applicable; no masking; primary purpose screening. Start 2022-08-29 (actual); primary completion 2022-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Performance of the Glyconics-SX System (ANODE02)
- Acronym
- ANODE02
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Near-infrared (NIR)
- Lead sponsor
- Glyconics Ltd
Record details
- Record id
cardio:ct-nct05476016- Content hash
f434840cfb89b63b0a3924f18e2755fc40ebdf091aa323d5ea01757ea8e53c63